AR062834A1 - Absorcion de larga duracion de flavonoides - Google Patents

Absorcion de larga duracion de flavonoides

Info

Publication number
AR062834A1
AR062834A1 ARP070103782A ARP070103782A AR062834A1 AR 062834 A1 AR062834 A1 AR 062834A1 AR P070103782 A ARP070103782 A AR P070103782A AR P070103782 A ARP070103782 A AR P070103782A AR 062834 A1 AR062834 A1 AR 062834A1
Authority
AR
Argentina
Prior art keywords
flavonoids
long
term absorption
absorption
term
Prior art date
Application number
ARP070103782A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR062834A1 publication Critical patent/AR062834A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01006—Endo-1,3(4)-beta-glucanase (3.2.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/0104—Alpha-L-rhamnosidase (3.2.1.40)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)

Abstract

Método para una liberacion a largo plazo y sostenida de flavonoides, en particular flavonoides que contengan ramnosa, y para prolongar la absorcion de dichos flavonoides en el tracto gastrointestinal. Composiciones que contienen dicho flavonoide y a- ramnosidasa. Composiciones que contienen hesperidina y heperetina 7-glucosido.
ARP070103782A 2006-08-24 2007-08-24 Absorcion de larga duracion de flavonoides AR062834A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06017678.1A EP1891967B1 (en) 2006-08-24 2006-08-24 Long-lasting absorption of flavonoids

Publications (1)

Publication Number Publication Date
AR062834A1 true AR062834A1 (es) 2008-12-10

Family

ID=37709496

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070103782A AR062834A1 (es) 2006-08-24 2007-08-24 Absorcion de larga duracion de flavonoides

Country Status (15)

Country Link
US (2) US8475786B2 (es)
EP (3) EP1891967B1 (es)
JP (1) JP5313896B2 (es)
CN (2) CN101516392A (es)
AR (1) AR062834A1 (es)
AU (1) AU2007287747B2 (es)
BR (1) BRPI0715373A2 (es)
CA (1) CA2661430A1 (es)
CL (1) CL2007002489A1 (es)
ES (3) ES2764221T3 (es)
MY (1) MY166022A (es)
PT (2) PT2054078T (es)
SG (1) SG174083A1 (es)
TW (1) TW200826948A (es)
WO (1) WO2008022784A2 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1891967B1 (en) 2006-08-24 2019-11-20 Société des Produits Nestlé S.A. Long-lasting absorption of flavonoids
JP5419366B2 (ja) * 2008-03-03 2014-02-19 東洋精糖株式会社 生体吸収性に優れたヘスペレチン組成物
JP2012001511A (ja) * 2010-06-18 2012-01-05 Nitto Yakuhin Kogyo Kk 配糖体分解用組成物
CN103224968B (zh) * 2013-05-06 2014-06-18 佛山市金骏康健康科技有限公司 一种酶法制备新橙皮苷的方法
JP2019510036A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド プロバイオティクス／プレバイオティクス有効成分を含む清浄剤組成物
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
AU2017365019A1 (en) 2016-11-23 2019-07-11 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US20200222474A1 (en) * 2017-07-24 2020-07-16 North Carolina State University Compositions and methods for increasing phytochemical bioavailablity and bioactivity
CN113817757B (zh) * 2021-10-25 2023-08-25 江南大学 一种生产樱桃苷的重组酵母工程菌株及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0908524B1 (en) 1997-03-24 2004-02-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing alpha-monoglucosylhesperidin-rich substance
JP2000078955A (ja) 1998-06-23 2000-03-21 Ezaki Glico Co Ltd 飲食物および薬品
AUPQ504300A0 (en) * 2000-01-11 2000-02-03 Biorex Health Limited Extraction of flavonoids
KR20030048427A (ko) * 2000-10-13 2003-06-19 가부시키가이샤 야쿠루트 혼샤 골대사 개선제
JP4846141B2 (ja) 2001-08-31 2011-12-28 東洋精糖株式会社 即効性および持続性を有するフラボノイド配糖体を含有する経口栄養補給剤
FR2841472B1 (fr) * 2002-06-28 2006-02-24 Agronomique Inst Nat Rech Composition nutritionnelle ou therapeutique contenant le compose hesperidine ou l'un de ses derives
US20040071685A1 (en) * 2002-10-09 2004-04-15 Devin Houston Compositions and methods for increasing the bioavailability of plant polyphenols
WO2004047766A2 (en) * 2002-11-25 2004-06-10 Kaloidis Antonia C Treatment for sma disease
EP1680508B1 (en) * 2003-10-28 2011-03-30 Friesland Brands B.V. Site-specific intestinal delivery and/or production of biologically active substances
WO2005058255A1 (en) * 2003-12-18 2005-06-30 Nestec S.A. Composition for improving skin, hair and coat health containing flavanones
EP1891967B1 (en) 2006-08-24 2019-11-20 Société des Produits Nestlé S.A. Long-lasting absorption of flavonoids

Also Published As

Publication number Publication date
WO2008022784A3 (en) 2008-10-30
EP2078758A3 (en) 2009-12-09
JP5313896B2 (ja) 2013-10-09
MY166022A (en) 2018-05-21
CL2007002489A1 (es) 2008-04-18
EP1891967A1 (en) 2008-02-27
EP2054078B1 (en) 2017-04-26
ES2764221T3 (es) 2020-06-02
EP2054078A2 (en) 2009-05-06
JP2010501503A (ja) 2010-01-21
CN101516392A (zh) 2009-08-26
AU2007287747A1 (en) 2008-02-28
EP2078758A2 (en) 2009-07-15
AU2007287747B2 (en) 2013-11-28
CA2661430A1 (en) 2008-02-28
WO2008022784A2 (en) 2008-02-28
ES2628702T3 (es) 2017-08-03
ES2601517T3 (es) 2017-02-15
BRPI0715373A2 (pt) 2013-06-25
PT2054078T (pt) 2017-07-11
US8475786B2 (en) 2013-07-02
US20130336941A1 (en) 2013-12-19
TW200826948A (en) 2008-07-01
EP1891967B1 (en) 2019-11-20
US20100055081A1 (en) 2010-03-04
SG174083A1 (en) 2011-09-29
CN102433286A (zh) 2012-05-02
EP2078758B1 (en) 2016-09-21
PT2078758T (pt) 2016-12-22

Similar Documents

Publication Publication Date Title
AR062834A1 (es) Absorcion de larga duracion de flavonoides
CL2011001966A1 (es) Composicion farmaceutica que comprende derivados de glucopiranosil difenilmetano como inhibidor sglt-2; forma farmaceutica que comprende una composicion farmaceutica; procedimiento de preparacion y uso en el control glucemico.
BRPI0817934A2 (pt) Combinação de lipo-quitooligossacarideo e flavonoide para crescimento de planta e rendimento aumentados
LTPA2017014I1 (lt) Farmacinė kompozicija, apimanti gliukopiranozil-pakeistojo benzeno darinį
BRPI0815170A2 (pt) Composição farmacêutica que compreende um inibidor de sglt 2
DK2069335T3 (da) Pyridin-3-ylderivater som immunomoduleringsmidler
DK3421471T3 (da) Purin- og deazapurinderivater som farmaceutiske forbindelser
DK3984528T3 (da) Farmaceutiske sammensætninger, som omfatter nilotinib
DK2094263T3 (da) 2-adamantyl-butyramidderivater som selektive 11 beta-hsd1-inhibitorer
EP2046290A4 (en) AQUEOUS DRONABINOL FORMULATIONS
DK2308841T3 (da) Phlorizinanaloge som SGLT2-inhibitorer
BRPI0815190A2 (pt) Composto derivado de piridina, composição farmacêutica que o compreende e uso do mesmo
CL2007003470A1 (es) Compuestos derivados de urea; composicion farmaceutica que comprende a dichos compuestos; y su uso como antibacterianos.
CR10160A (es) Arildihidroisoquinolinas sustituidas con azaciclilo, procedimiento para su preparacion y su uso como medicamentos
DK2078001T3 (da) Diazepan-acetamidderivater som selektive 11-HSD1-inhibitorer
DOP2007000043A (es) Derivados de cromanol sustituidos y su uso
BRPI0815821A2 (pt) Composições e métodos que empregam antagonistas nmda para alcançar um efeito poupador de anestésico.
NO20051467D0 (no) Orale doseringsformer som innbefatter gemcitabinderivater
DK2068891T3 (da) Sammensætning omfattende krebsdyr gastrolith komponenter, calciumcarbonat og anvendelse deraf
BRPI0905723A2 (pt) Uso de pelo menos uma semente de uma planta do gênero capsicum, composição e composição farmacêutica
CL2008000463A1 (es) Compuestos derivados de benzofuranos sustituidos; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar infecciones parasitarias.
DK2189062T3 (da) Planteekstrakter til anvendelse som phytokemikalier
DE602007005030D1 (de) Supraleitender Elektromagnet
DK2094638T3 (da) 2-aryl-2-fluorpropansyrer og derivater og farmaceutiske sammensætninger, der indeholder dem
CL2011002651A1 (es) Composicion veterinaria que comprende dipropionato de imidocarb, cianocobalamina vitamina b12 y un vehiculo farmaceuticamente aceptable; y su uso para tratar o prevenir enfermedades infecciosas parasitarias en ganado.

Legal Events

Date Code Title Description
FB Suspension of granting procedure